MainCumulative percent of PAS studies on publicly accessible PAS tracking website with expanded information abstracted, reviewed, and approvedCDRH maintains a publicly available webpage to keep all stakeholders informed of the progress of each PAS. The webpage displays general information regarding each PAS, as well as the overall study status (based on protocol-driven timelines and the adequacy of the data) and the applicant's reporting status for each submission due. To improve public access to and understanding of PAS information, CDRH plans to update the webpage with study purpose/goal and description for currently tracked studies. This will facilitate the delivery of information to the public by highlighting the most consequential details of a PAS.(1) September 2010: Complete expanded information (100% of 173 PAS studies) was made available in December 2010. Cumulative percent of PAS studies with expanded information was 0% until December 2010. Because the measure is retired for FY 2011, the final data is reported in the last month of the FY 2010 dashboard.Percentcolumn20100100TargetFY 2010 Target: 90% by 9/30/2010FY 2010 Overall: 100%SubCumulative percent of PAS studies on publicly accessible PAS tracking website with expanded information abstracted, reviewed, and approvedNumber of PAS studies with expanded information abstracted, reviewed, and approved during the monthNumbercolumn2010TargetFY 2010 Total: 173SubCumulative percent of PAS studies on publicly accessible PAS tracking website with expanded information abstracted, reviewed, and approvedCumulative number of PAS studies with expanded information abstracted, reviewed, and approved during the monthNumbercolumn2010TargetFY 2010 Total: 173SubCumulative percent of PAS studies on publicly accessible PAS tracking website with expanded information abstracted, reviewed, and approvedTotal number of PAS studies on publicly accessible PAS tracking websiteNumbercolumn2010TargetFY 2010 Total: 173http://www.fda.gov/AboutFDA/Transparency/track/ucm203038.htmFDA-TRACK CDRH Dashboardhttp://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas.cfmCDRH Post Approval Studies Tracking Website਍††਍਍਍਍਍਍਍